Literature DB >> 8110616

Mechanisms of pain in angina pectoris--a critical review of the adenosine hypothesis.

C Sylvén1.   

Abstract

Clinical characteristics: Angina pectoris represents a visceral pain caused by reversible myocardial ischemia. The majority of ischemic attacks are symptomless. When pain is manifested, it appears late during the ischemic event. The pain is complex in its quality and bears little relation to the region of myocardial ischemia. Pain shows a sensitive dependence on initial conditions suggesting a mechanism with deterministic chaotic dynamics for the association between myocardial ischemia and pain. Neurophysiological substrate: Ganglia are present within the heart, particularly in epicardial fat. The blood supply of intrinsic cardiac ganglia arises primarily from branches of the proximal coronary arteries. Both afferent and efferent neurons within the intrinsic cardiac nervous system exist, while the majority of neurons in that location may be local circuit neurons. Integration takes place not only in the intrinsic cardiac nervous system, but also in mediastinal, middle cervical, and stellate ganglia. Cardiac afferent receptors are also connected to cell bodies in dorsal root and nodose ganglia, as well as intrathoracic ganglia. Myocardial regions have no spatial representation in these ganglia. Adenosine, among a number of substances, can modulate the activity generated by cardiac afferent nerve endings and intrinsic cardiac neurons. Such effects appear to be exerted at A1 receptors. Adenosine as a pain messenger: During myocardial ischemia adenosine is released in large quantities into the interstitial space. The endothelium takes up the major amount of adenosine. Thus only small increments of adenosine are detected in the blood-stream. Given as an intravenous bolus to healthy volunteers or to patients with ischemic heart disease and angina pectoris, adenosine provokes angina pectorislike pain, which is similar to habitual angina pectoris with regard to quality and location. Pain is provoked in the absence of ECG signs of ischemia. Patients with asymptomatic myocardial ischemia are less sensitive to adenosine, whereas patients with Syndrome X are more sensitive with respect to adenosine-provoked pain. When adenosine is given intraarterially, including into the coronary arteries, pain is provoked in the corresponding vascular bed. Adenosine-provoked pain and ischemic pain are counteracted by previous administration of the adenosine receptor antagonist theophylline.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8110616     DOI: 10.1007/bf00878926

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  112 in total

1.  Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow.

Authors:  R M BERNE
Journal:  Am J Physiol       Date:  1963-02

2.  Improved working capacity in patients with ischaemic heart disease during a 10-day treatment with oral theophylline.

Authors:  E Strååt; A Edlund; P Henriksson
Journal:  J Intern Med       Date:  1992-07       Impact factor: 8.989

Review 3.  Pathophysiology of angina.

Authors:  P Collins; K M Fox
Journal:  Lancet       Date:  1990-01-13       Impact factor: 79.321

Review 4.  Mechanisms of purine-induced bronchoconstriction in asthma.

Authors:  S T Holgate; J P Finnerty; R Polosa
Journal:  Arch Int Pharmacodyn Ther       Date:  1990 Jan-Feb

Review 5.  Cellular abnormalities in chronically denervated myocardium. Implications for the transplanted heart.

Authors:  A J Drake-Holland; M I Noble
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

6.  Activity of canine in situ left atrial ganglion neurons.

Authors:  J A Armour; D A Hopkins
Journal:  Am J Physiol       Date:  1990-10

7.  Regulation of breathing in the rat: indications for a role of central adenosine mechanisms.

Authors:  T Hedner; J Hedner; P Wessberg; J Jonason
Journal:  Neurosci Lett       Date:  1982-11-30       Impact factor: 3.046

8.  Caffeine as an analgesic adjuvant.

Authors:  E M Laska; A Sunshine; F Mueller; W B Elvers; C Siegel; A Rubin
Journal:  JAMA       Date:  1984-04-06       Impact factor: 56.272

9.  Coronary effects of adenosine in conscious man.

Authors:  M Marzilli; G A Klassen; P Marraccini; P Camici; M G Trivella; A L'Abbate
Journal:  Eur Heart J       Date:  1989-11       Impact factor: 29.983

10.  Activity of in vivo canine ventricular neurons.

Authors:  J A Armour; D A Hopkins
Journal:  Am J Physiol       Date:  1990-02
View more
  6 in total

1.  Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X).

Authors:  P M Elliott; K Krzyzowska-Dickinson; R Calvino; C Hann; J C Kaski
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

Review 2.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

Review 3.  Adenosine triphosphate: established and potential clinical applications.

Authors:  H J Agteresch; P C Dagnelie; J W van den Berg; J H Wilson
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

Review 4.  [Angina pectoris in extracoronary diseases].

Authors:  A Wilke; B Noll; B Maisch
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

Review 5.  Clinical application of adenosine and ATP for pain control.

Authors:  Masakazu Hayashida; Ken-ichi Fukuda; Atsuo Fukunaga
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

Review 6.  Fractional flow reserve as a surrogate for inducible myocardial ischaemia.

Authors:  Tim P van de Hoef; Martijn Meuwissen; Javier Escaned; Justin E Davies; Maria Siebes; Jos A E Spaan; Jan J Piek
Journal:  Nat Rev Cardiol       Date:  2013-06-11       Impact factor: 32.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.